Evidence map›Paper›PMID 25210876›Full record

ArticlePLoS neglected tropical diseases2014

Co-infection of long-term carriers of Plasmodium falciparum with Schistosoma haematobium enhances protection from febrile malaria: a prospective cohort study in Mali.

Safiatou Doumbo, Tuan M Tran, Jules Sangala, Shanping Li, Didier Doumtabe, Younoussou Kone, Abdrahamane Traoré, Aboudramane Bathily, Nafomon Sogoba, Michel E Coulibaly and 9 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01322581 (A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in Mali), which is not on this map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01322581 completednot on this map

A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in Mali

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2011 to 2022Enrolled1,188ConditionsMalaria
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Prevalence of malaria andParasite epidemiology and control · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Safiatou DoumboMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Tuan M TranLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Jules SangalaMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Shanping LiLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Didier DoumtabeMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Younoussou KoneMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Abdrahamane TraoréMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Aboudramane BathilyMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Nafomon SogobaMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Michel E CoulibalyMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Chiung-Yu HuangDivision of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, United States of America.
Aissata OngoibaMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Kassoum KayentaoMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Mouctar DialloMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Zongo DramaneMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Thomas B NutmanLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Peter D CromptonLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Ogobara DoumboMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Boubacar TraoreMali International Center of Excellence in Research, University of Sciences, Techniques, and Technology of Bamako, Bamako, Mali.
Université des Sciences, des Techniques et des Technologies de Bamako · MLNational Institutes of Health · USNational Institute of Allergy and Infectious Diseases · USSidney Kimmel Comprehensive Cancer Center · US

Funding

Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodiesZIAAI001155 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CROMPTON, PETER · 2011 to 2025
$30.9M
Mali International Center for Excellence in Research: FilariasisZIAAI001063 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$3.2M
Intramural NIH HHS
6 · The paper itself

Abstract

backgroundMalaria and schistosomiasis often overlap in tropical and subtropical countries and impose tremendous disease burdens; however, the extent to which schistosomiasis modifies the risk of febrile malaria remains unclear.

methodsWe evaluated the effect of baseline S. haematobium mono-infection, baseline P. falciparum mono-infection, and co-infection with both parasites on the risk of febrile malaria in a prospective cohort study of 616 children and adults living in Kalifabougou, Mali. Individuals with S. haematobium were treated with praziquantel within 6 weeks of enrollment. Malaria episodes were detected by weekly physical examination and self-referral for 7 months. The primary outcome was time to first or only malaria episode defined as fever (≥ 37.5 °C) and parasitemia (≥ 2500 asexual parasites/µl). Secondary definitions of malaria using different parasite densities were also explored.

resultsAfter adjusting for age, anemia status, sickle cell trait, distance from home to river, residence within a cluster of high S. haematobium transmission, and housing type, baseline P. falciparum mono-infection (n = 254) and co-infection (n = 39) were significantly associated with protection from febrile malaria by Cox regression (hazard ratios 0.71 and 0.44; P = 0.01 and 0.02; reference group: uninfected at baseline). Baseline S. haematobium mono-infection (n = 23) did not associate with malaria protection in the adjusted analysis, but this may be due to lack of statistical power. Anemia significantly interacted with co-infection (P = 0.009), and the malaria-protective effect of co-infection was strongest in non-anemic individuals. Co-infection was an independent negative predictor of lower parasite density at the first febrile malaria episode.

conclusionsCo-infection with S. haematobium and P. falciparum is significantly associated with reduced risk of febrile malaria in long-term asymptomatic carriers of P. falciparum. Future studies are needed to determine whether co-infection induces immunomodulatory mechanisms that protect against febrile malaria or whether genetic, behavioral, or environmental factors not accounted for here explain these findings.

Indexed as

AdolescentAdultAnimalsChildChild, PreschoolCoinfectionFemaleHumansInfantMalaria, FalciparumMaleMaliPlasmodium falciparumProspective StudiesSchistosoma haematobiumSchistosomiasis haematobia

Identifiers

PMID25210876
PMCPMC4161351
OpenAlexW2014055571

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.